International Clinical Trial: A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Lercanidipine HCl 20 mg tablets relative to ZANIDIP 20 mg tablets in healthy Thai participants under fasting condition - a pilot study

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260405009) titled 'A Bioequivalence study of a randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence of Lercanidipine HCl 20 mg tablets relative to ZANIDIP 20 mg tablets in healthy Thai participants under fasting condition - a pilot study' on April 5.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Dr. Sasitorn Kittivoravitkul

Condition: Healthy volunteers Bioequivalence Lercanidipine HCl 20 mg tablets Bioequivalence Lercanidipine HCl 20 mg tablets

Intervention: The new generic products which were recently developed. Volunteer will receive a single...